TERN- Terns Pharmaceuticals, Inc.

Name: Terns Pharmaceuticals, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Terns Pharmaceuticals, Inc. (TERN) has 10 insiders with recent SEC Form 4 filings, including 9 buys and 3 sells. TERN is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
CEO	Burroughs Amy L.	296.5K	$15.70M	-
Other	Kuriakose Emil	112.5K	$5.96M	-
CFO	Gengos Andrew	101.8K	$5.39M	-
Dir	Lu Hongbo	45.0K	$2.38M	-
Dir	Fellows David A	2.8K	$149.7K	-

Activity

Buys and sells only

Transactions

10 filings · page 4

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
May 31, 2023	Vignola Mark J.67	Chief Financial Officer	Buy	9,997	$1.41	$14,095.77	+130.5%	-48.2%	-33.8%
Dec 23, 2022	Gordon Carl L74	Director, 10% Owner	Buy	137,931	$7.25	$999,999.75	+2.9%	+10.3%	-20.5%
Dec 23, 2022	Orbimed Advisors LLC67	Director, 10% Owner	Buy	137,931	$7.25	$999,999.75	+2.9%	+10.3%	-20.5%
Dec 23, 2022	Vivo Opportunity, LLC67	10% Owner	Buy	758,620	$7.25	$5,499,995.00	+21.2%	+10.3%	-20.5%
Dec 23, 2022	Lu Hongbo59	Director	Buy	758,620	$7.25	$5,499,995.00	+21.2%	+10.3%	-20.5%
Nov 30, 2022	Yoon Seokho Bryan62	COO And General Counsel	Buy	3	$1.41	$4.23	-	+30.4%	-42.7%
Nov 30, 2022	Vignola Mark J.67	Chief Financial Officer	Buy	3	$1.41	$4.23	-	+30.4%	-42.7%
Nov 30, 2022	Sundaram Senthil Vel56	Chief Executive Officer	Buy	3	$1.41	$4.23	-	+30.4%	-42.7%
Nov 23, 2022	Lav Biosciences Fund V, L.P.	10% Owner	Sell	1,500,000	$5.50	$8,250,000.00	-42.9%	+90.7%	-30.1%
Sep 7, 2022	Vivo Opportunity, LLC67	10% Owner	Buy	600,000	$3.60	$2,160,000.00	+20.1%	+54.2%	+37.6%

← PrevPage 4Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC